MRI scans, magnesium diboride

March 26, 2014 -- Based on its recent analysis of the superconductor technology for MRI market, Frost & Sullivan recognizes Cutting Edge Superconductors, Inc. with the 2013 North American Frost & Sullivan Award for Technology Innovation Leadership. CES, Inc. developed a proprietary technology based on magnesium diboride superconducting wire, which enabled cryogen-free 1.5T and 3.0T magnetic resonance imaging (MRI) with image qualities similar to the currently available 1.5T MRI. The technology leveraged innovative customizations in the chemistry of the material by adding both magnetic and non-magnetic impurities to magnesium diboride wires. This resulted in improvements to the critical currents of superconducting magnesium diboride wires.
 
The cryogen-free 0.5T MRI delivers images of average quality when compared to 1.5T MRI, as the quality of image is directly dependent on the square of the strength of the magnetic field. However, the current 1.5T MRI technology requires the use of cost-intensive liquid helium, which increases the cost of maintenance and operation, as well as initial cost.
 
"The next-generation, cryogen-free 1.5T and 3.0T MRI technology promises a reduction in the MRI scan cost by up to 40 percent due to the financial viability and simplicity of the MRI equipment," said Frost & Sullivan Senior Research Analyst Avimanu Basu. "This cost-effectiveness is achieved by maintaining a higher operating temperature of 20 degrees K with the help of a cryocooler, which eliminates the need for expensive liquid helium."
 
Furthermore, the technology is maintenance-free and extends the equipment's longevity to 10 to 20 years. The presently available MRI has a lifetime of five to seven years and is complex and expensive to maintain, as it employs superconducting NbTi wires that operate at a temperature of 4 degrees K. This necessitates cooling with the help of 1,700 liters of liquid helium cryogen.
 
"CES, Inc.'s technology is aimed at improving the current-carrying capacity of wires and thus, the field strength of the magnet," noted Basu. "On the one hand, this makes the device more industrially viable and simple and on the other, it supports the development of a range of applications across industries."
 
The technology is expected to influence a wide spectrum of industries such as electrical power (generation, transmission, and distribution), healthcare, air travel and defense. It can also be applied in high-performance cryogen-free magnets for scientific nuclear magnetic resonance (NMR), accelerators and fusion reactors. In addition, it can benefit small hospitals in economically unstable nations in the form of low-cost, high-quality portable MRI.
 
Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing a technology, which significantly impacts both the functionality and the customer value of new products and applications. The award lauds the relevance of the innovation to the industry.
 

Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Artificial Intelligence

December 22, 2023 — Quibim, a company pioneering imaging biomarkers for Precision Medicine that has created AI-based ...

Time December 22, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

December 20, 2023 — Terran Biosciences, Inc., a biotech platform company developing therapeutics and technologies for ...

Time December 20, 2023
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
News | Artificial Intelligence

December 5, 2023 — Radiology is under severe economic pressure as reimbursement rates fall for many common scans. At the ...

Time December 05, 2023
arrow
News | Artificial Intelligence

December 5, 2023 — Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro, the next-generation AI software for brain ...

Time December 05, 2023
arrow
News | RSNA

December 1, 2023 — Royal Philips, a global leader in health technology, put patients and healthcare providers center ...

Time December 01, 2023
arrow
Subscribe Now